Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator

被引:73
|
作者
Cotten, JF
Ostedgaard, LS
Carson, MR
Welsh, MJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242
[3] UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
关键词
D O I
10.1074/jbc.271.35.21279
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cystic fibrosis transmembrane conductance regulator (CFTR) contains multiple membrane spanning sequences that form a Cl- channel pore and cytosolic domains that control the opening and closing of the channel. The fourth intracellular loop (ICL4), which connects the tenth and eleventh transmembrane spans, has a primary sequence that is highly conserved across species, is the site of a preserved sequence motif in the ABC transporter family, and contains a relatively large number of missense mutations associated with cystic fibrosis (CF). To investigate the role of ICL4 in CFTR function and to learn how CF mutations in this region disrupt function, we studied several CF-associated ICL4 mutants. We found that most ICL4 mutants disrupted the biosynthetic processing of CFTR, although not as severely as the most common Delta F508 mutation. The mutations had no discernible effect on the channel's pore properties; but some altered gating behavior, the response to increasing concentrations of ATP, and stimulation in response to pyrophosphate. These effects on activity were similar to those observed with mutations in the nucleotide-binding domains, suggesting that ICL4 might help couple activity of the nucleotide-binding domains to gating of the Cl- channel pore. The data also explain how these mutations cause a loss of CFTR function and suggest that some patients with mutations in ICL4 may have a milder clinical phenotype because they retain partial activity of CFTR at the cell membrane.
引用
收藏
页码:21279 / 21284
页数:6
相关论文
共 50 条
  • [1] Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of CFTR.
    Cotten, JF
    Ostedgaard, LS
    Carson, MR
    Welsh, MJ
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A228 - A228
  • [2] Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis
    de Araujo Correia Coutinho, Cyntia Arivabeni
    de Lima Marson, Fernando Augusto
    Ribeiro, Antonio Fernando
    Ribeiro, Jose Dirceu
    Bertuzzo, Carmen Silvia
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2013, 39 (05) : 555 - 561
  • [3] Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function
    Clain, J
    Fritsch, J
    Lehmann-Che, J
    Bali, M
    Arous, N
    Goossens, M
    Edelman, A
    Fanen, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9045 - 9049
  • [4] CYSTIC-FIBROSIS WITH 3 MUTATIONS IN THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE
    DORK, T
    WULBRAND, U
    RICHTER, T
    NEUMANN, T
    WOLFES, H
    WULF, B
    MAASS, G
    TUMMLER, B
    [J]. HUMAN GENETICS, 1991, 87 (04) : 441 - 446
  • [5] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Parisi, Giuseppe Fabio
    Mollica, Federico
    Giallongo, Alessandro
    Papale, Maria
    Manti, Sara
    Leonardi, Salvatore
    [J]. EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)
  • [6] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Giuseppe Fabio Parisi
    Federico Mòllica
    Alessandro Giallongo
    Maria Papale
    Sara Manti
    Salvatore Leonardi
    [J]. Egyptian Journal of Medical Human Genetics, 23
  • [7] Clinical implications of cystic fibrosis transmembrane conductance regulator mutations
    Mickle, JE
    Cutting, GR
    [J]. CLINICS IN CHEST MEDICINE, 1998, 19 (03) : 443 - +
  • [8] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [9] Novel cystic fibrosis transmembrane conductance regulator variant in a cystic fibrosis patient
    Baeza-Trinidad, Ramon
    Garcia-Guerreros, Sandra
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 (03) : 508 - 509
  • [10] Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein
    Riordan, JR
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) : 1499 - 1504